Skip to main content

Table 3 Number of patients with ≥10-point score deterioration and improvement in HR-QOL from baseline in each category of NCF by using three cut-off values at 4 months

From: The neurocognitive function change criteria after whole-brain radiation therapy for brain metastasis, in reference to health-related quality of life changes: a prospective observation study

 

n (%: n/No. of patient category)

p-value

p-value

DETERIORATION

Improvement

Stable

Deterioration

Both

Deterioration vs. others

Deterioration/Both vs. others

QLQ-C30:

 Global Health Status

  1.0 SD

2 (33)

2 (40)

4 (24)

4 (31)

0.729

0.701

  1.5 SD

2 (25)

4 (44)

3 (20)

3 (33)

0.480

0.507

  2.0 SD

1 (14)

6 (40)

3 (20)

2 (50)

0.480

0.744

 Functional scales

  1.0 SD

1 (17)

1 (20)

9 (53)

1 (8)

0.013*

0.457

  1.5 SD

1 (13)

2 (22)

8 (53)

1 (11)

0.015*

0.296

  2.0 SD

1 (14)

3 (20)

7 (47)

1 (25)

0.083

0.168

 Symptom scales

  1.0 SD

2 (33)

1 (20)

8 (47)

4 (31)

0.328

0.716

  1.5 SD

2 (25)

3 (33)

7 (47)

3 (33)

0.336

0.519

  2.0 SD

2 (29)

6 (40)

6 (40)

1 (25)

0.749

1.000

QLQ-BN20:

 1.0 SD

2 (33)

0 (0)

8 (47)

5 (39)

0.328

0.168

 1.5 SD

2 (25)

2 (22)

7 (47)

4 (44)

0.336

0.195

 2.0 SD

2 (29)

4 (27)

7 (47)

2 (50)

0.336

0.211

IMPROVEMENT

Improvement

Stable

Deterioration

Both

Improvement vs. others

Improvement/Both vs. others

QLQ-C30:

 Global Health Status

  1.0 SD

3 (50)

1 (20)

1 (20)

5 (39)

0.393

0.346

  1.5 SD

3 (38)

2 (22)

2 (22)

5 (56)

1.000

0.189

  2.0 SD

3 (43)

4 (27)

4 (27)

2 (50)

0.673

0.463

 Functional scales

  1.0 SD

4 (67)

1 (20)

1 (20)

4 (31)

0.168

0.533

  1.5 SD

5 (63)

3 (33)

3 (33)

2 (22)

0.117

0.745

  2.0 SD

4 (57)

5 (33)

5 (33)

1 (25)

0.390

0.491

 Symptom scales

  1.0 SD

2 (33)

1 (20)

1 (20)

3 (23)

0.651

1.000

  1.5 SD

3 (38)

3 (33)

3 (33)

2 (22)

0.658

1.000

  2.0 SD

2 (29)

4 (27)

4 (27)

1 (25)

1.000

1.000

QLQ-BN20:

 1.0 SD

3 (50)

1 (20)

1 (20)

1 (8)

0.077

1.000

 1.5 SD

4 (50)

1 (11)

1 (11)

0 (0)

0.033*

0.698

 2.0 SD

2 (29)

3 (20)

3 (20)

0 (0)

0.606

1.000

  1. *p-value < 0.05
  2. Both significant improvement and deterioration were observed in different NCF domains HR-QOL health-related quality of life, NCF neurocognitive function. QLQ-C30 European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30. QLQ-BN20 European Organization for Research and Treatment of Cancer (EORTC) Brain Cancer Module